Total raised
$500K
Stage
Pre-Funding
Founded
2016
Headcount
6
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
Zolex Therapeutics is a recently established drug company focusing on the development of new classes of orally active, small-molecular-weight antibiotics that target Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus strains. Zolex Therapeutics is located within the RadBioMed Accelerator at Ramat Hachayal, Tel Aviv, and is led by Dr. Lewis Neville and Dr. Ziv Lifshitz.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of Zolex Therapeutics?
- Zolex Therapeutics focuses on developing new classes of orally active, small-molecular-weight antibiotics to target Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus strains.
- When was Zolex Therapeutics founded?
- Zolex Therapeutics was founded in August 2016.
- What is the current status of Zolex Therapeutics?
- Zolex Therapeutics is currently inactive as of November 2018.
- Where is Zolex Therapeutics located?
- Zolex Therapeutics is located in Tel Aviv-Yafo, Israel, specifically within the RadBioMed Accelerator at Ramat Hachayal.
- Who leads Zolex Therapeutics?
- Zolex Therapeutics is led by Dr. Lewis Neville and Dr. Ziv Lifshitz.
- What was the total amount of funding raised by Zolex Therapeutics?
- Zolex Therapeutics raised a total of $500,000 USD.
- Did Zolex Therapeutics receive any grants?
- Yes, in December 2016, Zolex Therapeutics received a grant of $500,000 USD from the IIA.
- What is the employee count for Zolex Therapeutics?
- Zolex Therapeutics has an employee count in the range of 1-10, with an exact count of 6 employees.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
pharmaceuticalsantibioticspharma-companiesantibodiesdrug-discoverybiopharmaceutical